NEW YORK, March 7 - Biotech companies, including genomics-firms-cum-drug-discoverers, will get to keep the Prescription Drug User Fee Act, but it'll cost them a bit more than they're used to.

After seven months of back-room negotiations, the US Food and Drug Administration and the pharmaceutical and biotechnology industries have come to a provisional agreement on a new version of the popular act.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.